Dr. Yassir Javaid, Award-Winning Cardiologist, Strengthens UK Clinical Board for PMcardio
We are happy to share that Dr. Yassir Javaid, a distinguished General Practitioner specialising in Cardiology, has joined our UK Clinical Board. Recognised for his dynamic integration of primary care experience and cardiology expertise, Dr. Javaid brings a valuable and strategic perspective to our team.
We are happy to share that Dr. Yassir Javaid, a distinguished General Practitioner specialising in Cardiology, has joined our UK Clinical Board. Recognised for his dynamic integration of primary care experience and cardiology expertise, Dr. Javaid brings a valuable and strategic perspective to our team.
Dr. Javaid’s expertise in the UK healthcare market and his patient-centric approach, recognized by the GP of the Year Award, blend perfectly with our mission. His proficiency in bridging the gap between primary care and specialised cardiology will significantly aid us in navigating the complexities of the British market, aligning our innovative AI-based solutions with the specific needs of patients and healthcare providers.
His addition to our board not only signifies a synergistic relationship between his expertise and our commitment to innovative, patient-focused research but also amplifies our ability to understand and address the demands of the UK’s unique healthcare landscape.
Driven by an unwavering commitment to continual learning in cardiology, Dr. Javaid’s insights will undoubtedly deepen our understanding of patient needs, shaping research initiatives that will make tangible improvements in primary, emergency and hospital care across the UK.
Many of you may already be familiar with Dr. Javaid from our webinar on “The Diagnosis and Management of Atrial Fibrillation”. His thoughtful contributions to this session are a testament to his dedication to healthcare education. If case you missed the webinar, we invite you to watch it.
About Dr. Yassir Javaid Dr Javaid qualified from Cambridge University and completed his VTS training in Northampton. He has a specialist interest in cardiology and echocardiography and was a clinical lead in the Northamptonshire Community Cardiology service, which had a focus on patients with heart failure and valve disease. He was named Pulse “GP of the Year” in 2015 for his work in reducing stroke emergency admissions in the East Midlands. He is on the editorial board for the British Journal of Cardiology.
Share this article
About PMcardio
PMcardio is a CE-marked Class IIb AI medical device that interprets any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.
